Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 4,551–4,575 of 7,816 matching trials · page 183 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Nicotinic Cholinergic Modulation as a Novel Treatment Strategy for Aggression Associated With Autism NCT02552147 Transdermal nicotine; Transdermal placebo Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 8 | Yale University OTHER |
2022-05-06 |
|
Effects of tACS Combined With CCT for Patients With MCI NCT04135742 Transcranial Alternating Current Stimulation; Cognitive Training Runs in: China · 2 sites |
NA other |
UNKNOWN | 195 | Shanghai Mental Health Center OTHER |
2022-05-06 |
|
Pharmacokinetics Centella Asiatica Product (CAP) in Mild Cognitive Impairment NCT03937908 2g Centella asiatica water extract product; 4g Centella asiatica wa... Runs in: United States · 1 site |
EARLY_PHASE1 other |
TERMINATED | 5 | Oregon Health and Science University OTHER |
2022-05-04 |
|
Complex Eye Movements in Parkinson's Disease and Related Movement Disorders NCT04925622 Complex eye movement exam Runs in: United States · 1 site |
NA other |
COMPLETED | 90 | Saccadous, Inc. OTHER |
2022-05-04 |
|
Study Evaluating the Safety and Pharmacokinetics of a Single Dose of GSI-953 NCT00441987 GSI-953 Runs in: Japan · 1 site |
PHASE1 other |
COMPLETED | 96 | Wyeth is now a wholly owned subsidiary of Pfizer INDUSTRY |
2022-05-03 |
|
Dementia Risk and Dynamic Response to Exercise NCT04009629 Moderate Intensity Aerobic Exercise Runs in: United States · 1 site |
NA other |
COMPLETED | 61 | University of Kansas Medical Center OTHER |
2022-05-03 |
|
Effects of Perioperative TEAS on Postoperative Pain and Agitation in Pediatric Adenoidectomy and Tonsillectomy NCT05330494 transcutaneous electrical acupoint stimulation(TEAS) Runs in: China · 1 site |
NA other |
UNKNOWN | 200 | Xian Children's Hospital OTHER_GOV |
2022-05-03 |
|
A Study in Subjects With Late Prodromal & Early Manifest HD to Assess the Safety, Tolerability, pk, and Efficacy of Pepi NCT02481674 VX15/2503; Placebo Runs in: Canada; United States · 32 sites |
PHASE2 other |
COMPLETED | 301 | Vaccinex Inc. INDUSTRY |
2022-05-02 |
|
Constitution of a Clinico-radiological Database and a Biobank for Patients With Lacunar Infarcts NCT03552926 Runs in: France · 1 site |
NA other |
RECRUITING | 500 | Assistance Publique - Hôpitaux de Paris OTHER |
2022-05-02 |
|
Predictive Factors of Autonomy Loss in Real-life Cohort NCT03894254 no intervention Runs in: France · 5 sites |
NA other |
RECRUITING | 5,400 | Hospices Civils de Lyon OTHER |
2022-05-02 |
|
Major Memory 2: A Long-term Group Cognitive Stimulation Program NCT04178564 Cognitive Stimulation Runs in: Portugal · 8 sites |
NA other |
SUSPENDED | 70 | Rsocialform - Geriatria, Lda OTHER |
2022-05-02 |
|
Telerehabilitation Alzheimer's Disease Feasibility (TADF) NCT04732182 BrightGo cognitive training; Standard of Care medication for early ... Runs in: United States · 2 sites |
NA other |
UNKNOWN | 14 | Bright Cloud International Corp INDUSTRY |
2022-05-02 |
|
Clinical Dementia Rating Medical Record NCT04763941 CDR assessment face-to-face Runs in: France · 1 site |
NA other |
UNKNOWN | 144 | Hospices Civils de Lyon OTHER |
2022-05-02 |
|
Telerehabilitation Cognitive Impairments Following Chemotherapy Feasibility Study NCT04972019 Telerehabilitation Experimental Group; Telerehabilitation Sham Cont... Runs in: United States · 2 sites |
NA other |
UNKNOWN | 40 | Bright Cloud International Corp INDUSTRY |
2022-05-02 |
|
Effects of Transdermal Nicotine on Response Inhibition to Emotional Cues in Schizophrenia NCT03838484 Nicotine Patch, 7 Mg/24 Hr; Placebo patch Runs in: United States · 1 site |
NA other |
TERMINATED | 18 | Vanderbilt University Medical Center OTHER |
2022-04-29 |
|
Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions NCT04684602 PrimePro™/ PrimeMSK™ Runs in: United States · 1 site |
PHASE1|PHASE2 other |
RECRUITING | 5,000 | Thomas Advanced Medical LLC INDUSTRY |
2022-04-29 |
|
Listen Carefully: An Exploratory Study of the Association Between Listening Effort and Cognitive Function NCT04593290 Oticon Opn S 1 miniRITE hearing aid Runs in: Denmark · 1 site |
NA other |
COMPLETED | 24 | Technical University of Denmark OTHER |
2022-04-28 |
|
Mindfulness-Based Stress Reduction in Dementia Caregivers NCT04977245 Mindfulness-Based Stress Reduction; Self-Guided Mindfulness eCourse Runs in: United States · 1 site |
NA other |
COMPLETED | 40 | University of California, San Francisco OTHER |
2022-04-28 |
|
Telerehabilitation Alzheimer's Disease Usability (TADU) NCT04731311 Usability evaluation of BrightGo computerized device for cognitive ... Runs in: United States · 1 site |
NA other |
COMPLETED | 4 | Bright Cloud International Corp INDUSTRY |
2022-04-27 |
|
Utility of Amantadine Hydrochloride in the Treatment of Post-traumatic Irritability NCT00627250 Amantadine |
NA other |
COMPLETED | 76 | Wake Forest University Health Sciences OTHER |
2022-04-25 |
|
Safety and Tolerability of WVE-120102 in Patients With Huntington's Disease NCT03225846 WVE-120102; Placebo Runs in: Australia; Canada; Denmark; France; Germany; Poland; Unit... · 26 sites |
PHASE1|PHASE2 other |
TERMINATED | 88 | Wave Life Sciences USA, Inc. INDUSTRY |
2022-04-25 |
|
Creating Physical Objects With 3D Printers to Stimulate Reminiscing for Memory Loss [2 R44 AG049548-02A1] NCT03625973 3D-RT; RT-Verbal Runs in: United States · 2 sites |
NA other |
UNKNOWN | 150 | Moai Technologies LLC OTHER |
2022-04-25 |
|
Carbamazepine for the Treatment of Chronic Post-Traumatic Brain Injury Irritability and Aggression NCT00621751 Carbamazepine; Placebo Runs in: United States · 1 site |
NA other |
COMPLETED | 70 | Wake Forest University Health Sciences OTHER |
2022-04-22 |
|
The Effect of Digital Reminiscence Therapy on People With Mild and Moderate Dementia NCT05341271 Experimental: digital reminiscence group (DRG); Experimental: gener... Runs in: Taiwan · 1 site |
NA other |
UNKNOWN | 186 | National Taipei University of Nursing and Health Sciences OTHER |
2022-04-22 |
|
Social Support Aid For People With Dementia NCT03645694 Social Support Aid |
PHASE2 other |
COMPLETED | 48 | University of Minnesota OTHER |
2022-04-21 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial